Haematopoietic stem and progenitor cell (HSPC) research has significantly contributed to the understanding and harnessing of haematopoiesis for regenerative medicine. However, the methodology for real-time tracking HSPC in vivo is still lacking, which seriously restricts the progress of research. Recently, magnetic carbon nanotubes (mCNT) have generated great excitement because they have been successfully used as vehicles to deliver a lot of biomolecules into various cells. There is, however, no report about mCNT being used for tracking HSPC. In this paper, we investigated the uptake efficiency of fluorescein-isothiocyanate-labelled mCNT (FITC-mCNT) into HSPC and their effect on the cytotoxicity and differentiation of HSPC. We found that cellular uptake of FITC-mCNT was concentration-and time-dependent. The uptake of FITC-mCNT into HSPC reached up to 100% with the highest mean fluorescence (MF). More importantly, efficient FITC-mCNT uptake has no adverse effect on the cell viability, cytotoxicity and differentiation of HSPC as confirmed by colony-forming unit assay (CFU). In conclusion, the results reported here suggest the further tailoring of mCNT for their use in HSPC labelling/tracking in vivo or gene delivery into HSPC.
Introduction
Nanotechnology, focused on assembling nanoscale elements to form complex structures, has set high expectations in biology and medicine in the last decade. Given the fact that many biological processes operate at the nanometre scale, it is not surprising that nanomaterials can provide tools to direct these biological processes [1] . Recent years have seen increasing interest in the biological and biomedical applications of nanomaterials such as carbon nanotubes (CNT) [2] [3] [4] [5] [6] [7] [8] . The novel optical, mechanical, electrical or magnetic properties of CNT have stimulated extensive research, including their use in biosensing, tissue engineering and molecular delivery [3] [4] [5] [6] [7] [9] [10] [11] [12] . Nanospearing molecular delivery, which relies on the penetration of magnetic carbon nanotubes (mCNT) into cells by magnetic field exposure, has been receiving considerable attention for its high efficiency in gene delivery into tumour cell lines, such as breast cancer cells, MCF-7, and difficult-to-transfect cells, primary mammalian neurons and B lymphocytes [5] . Recently, we also reported the magnetic-field-driven high internalization of fluoresceinisothiocyanate-labelled mCNT (FITC-mCNT) into MCF-7 and the suspension human acute monocytic leukaemia cell line, namely THP-1, which is intrinsically a difficult target for molecular delivery or transfection [13] . Nanomaterialmediated delivery using CNT can also be used for cellular labelling/tracking [14, 15] . CNT coated with the peptide has been reported to be successfully delivered and imaged in living human cervical cancer cells HeLa [14] . More interestingly, CNT fluorescence was detected and imaged from living Drosophila larva by using near-infrared (NIR) while not adversely affecting the viability and growth of the larva by ingestion in another study [15] . Although CNT-mediated delivery has already been successfully applied in various cells, their proposed use in stem cells is more recent. CNT have been shown to efficiently label human mesenchymal stem cells (hMSC) and not affect biocompatibility, proliferation or differentiation properties of these cells [16] . However, the uptake or labelling efficiency of CNT in haematopoietic stem/progenitor cells (HSPC) has not been addressed or explored yet (HSPC are the most common type of stem cells used for cellular therapies for many decades [17, 18] ).
HSPC are the very-well-characterized, rare and renewable population of cells that give rise to all of the differentiated cells of adult peripheral blood.
Transplantation of HSPC obtained from peripheral blood (PB), bone marrow (BM) or from umbilical cord blood (CB) has been routinely used to rescue bone marrow function following high-dose myeloablative therapy for non-malignant and malignant haematologic disorders such as leukaemias [18, 19] . Nonetheless, little is understood about the biology of HSPC homing and engraftment to the BM microenvironment after transplantation [20] . HSPC were reported not to engraft with absolute efficiencies to the BM, though donor-derived HSPC have been detected in various organs following transplantation [21] [22] [23] . Therefore, labelling HSPC and the consecutive non-invasive tracking in vivo following transplantation become important in understanding HSPC homing/engraftment and the therapeutic efficacy for future stem-cell-based therapies. Labelling HSPC prior to application in humans must be highly efficient and safe. Recent developments in nanotechnology allow the visualization of HSPC infused into a live recipient. For instance, the use of magnetic nanoparticles conjugated to the Tat protein of HIV offers the possibility of labelling highly purified HSPC subsets at 24 h incubation, and the specific homing and trafficking of the labelled cells can be monitored in vivo using MRI afterwards [24] . However, more studies are needed to fully explore the possibilities of the CNT-mediated labelling of HSPC for cell tracking. In this paper, we investigate the uptake efficiency of FITC-mCNT into HSPC and their effect on cytotoxicity and the differentiation of HSPC.
Materials and methods

Preparation of FITC-mCNT
Single-walled mCNT containing Ni and Y at the tip, with an average diameter of 1.2-1.5 nm and a length of 2-5 µm, were obtained from Sigma-Aldrich (Ontario, Canada). These specific mCNT were chosen for our experiment because they have been used in magnetic-field-driven biomolecule delivery with very high efficiency [5] . Compared to the reported methods, our synthesis of FITC-mCNT is much simpler and yet returns higher chemical yields [25] . As shown in figure 1 , the mCNT were oxidized to form carboxylic acid groups on the surface [5, [26] [27] [28] [29] , which were reacted with thionyl chloride and then 2 -(ethylenedioxy)bis(ethylamine) to produce amineterminated nanotubes. The amine was then reacted with FITC to provide FITC-labelled highly water-soluble FITCmCNT. Infrared (IR), x-ray photoelectron spectroscopy (XPS) and UV-vis spectroscopy were used to validate the chemical reactions of the intermediate and the final FITC-mCNT products.
Oxidation of the carbon nanotubes.
The first oxidation step was carried out as described previously [5, [26] [27] [28] [29] . Briefly, the purchased carbon nanotubes (200 mg) were refluxed with 0.5 M HNO 3 (100 ml) for 48 h to introduce carboxylic groups. After refluxing, the solution was diluted with deionized water, filtered over a 0.2 µm polycarbonate filter (Millipore) and washed several times with deionized water. The sample was collected and dried overnight in a vacuum oven at 80
• C to give mCNT 2 (170 mg) (figure 1).
Reaction with thionyl chloride to give SWNT-COCl.
A suspension of mCNT 2 (100 mg) in 20 ml of SOCl 2 , together with five drops of dimethylformamide (DMF), was stirred at 70
• C for 24 h. The mixture was cooled and centrifuged at 2000 rpm for 30 min. The excess SOCl 2 was decanted and the resulting black solid was washed with anhydrous THF (3 × 20 ml) and dried overnight in a vacuum oven at 80
• C to give mCNT 3 (78 mg) (figure 1).
Coupling with 2-(2-(2-aminoethoxy)ethoxy)ethanamine.
The mixture of mCNT 3 (50 mg) and anhydrous 2-(2-(2-aminoethoxy)ethoxy)ethanamine (120 ml) was heated at 100
• C for 100 h. During this time, the liquid phase became dark. After cooling, the mixture was poured into methanol (100 ml) and centrifuged to give a black solid, which was washed several times with methanol. The resulting solid was dried overnight in a vacuum oven at 80
• C to give mCNT 4 (42 mg) (figure 1).
Labelling with FITC.
A suspension of the mCNT 4 (25 mg) and FITC (5 mg) in anhydrous DMF (10 ml) was stirred in the dark for 5 h. Then the reaction mixture was poured into anhydrous ethyl ether (40 ml) and centrifuged to give a black solid, which was washed with methanol until TLC (10% MeOH in dichloromethane) showed no free FITC left. The product was dried overnight in a vacuum oven at 80
• C to give mCNT 5 (23 mg) (figure 1).
Enrichment of human CD34
+ HSPC and viability testing CB was collected immediately after delivery in a sterilized tube containing heparin (1000 IU ml −1 ), and with the informed consent of the mother (in accordance with the institutional Figure 1 . Schematic illustration of FITC-mCNT synthesis and magnetic-field-driven FITC-mCNTs into HSPCs. The mCNTs (1) were oxidized to form carboxylic acid groups on the surface (2). These nanotubes were reacted with thionyl chloride (3) and then 2 -(ethylenedioxy)bis(ethylamine) to produce amine-terminated nanotubes (4). The amine was then reacted with FITCs to form highly water-soluble FITC-mCNTs (5). Freshly synthesized fluorescent and magnetic FITC-mCNTs were then used in magnetic-field-driven HSPC uptake experiments.
guidelines approved by the Health Research Ethics Board of the University of Alberta).
Peripheral blood leukapheresis product (LP) was obtained with the patients' informed consent (in accordance with the institutional guidelines approved by the Human Research Ethics Board of the University of Alberta) before cryopreservation. Light density cells from CB and LP were obtained by Percoll density gradient centrifugation and enriched for CD34 + cells by immunoaffinity selection with MACS paramagnetic beads (Miltenyi Biotec, Auburn, CA, USA), according to the manufacturer's instructions as described previously [30] . The purity of isolated CB and LP CD34 + cells were >95% and >91%, respectively, as determined by fluorescence-activated cell sorter (FACS) analysis. Cell viability was measured by the trypan blue exclusion assay.
Magnetic-field-driven cellular uptake experiment
CD34
+ cells with a density of 2.5-3 × 10 5 cells/plate were placed in poly-L-lysine (10 µg ml −1 )-coated p35 mm culture dishes and incubated for 45 min at 37
• C, 5% CO 2 .
The magnetic-field-driven delivery method was applied as described previously [5] . Culture dishes were vertically placed into a beaker containing 50 ml serum-free IMDM media with different concentrations of FITC-mCNT or mCNT (10, 20 and 40 µg ml −1 ) and then the beaker was placed on a magnetic stirrer set up at 1200 rpm for 10 min. Culture dishes were then transferred to an Nd-Fe-B permanent magnet for another 10 min. The uptake experiment was terminated by washing the cells with PBS and the cells were incubated for 1, 3, 6, 24 and 48 h at 37
• C, 5% CO 2 for uptake efficiency of FITC-mCNT.
FACS analysis
The cells exposed to FITC-mCNT at different time points and concentrations were collected, extensively washed and then fixed in 1% paraformaldehyde prior to FACS analysis (FACscan, Becton-Dickinson, San Jose, CA, USA) to determine uptake efficiencies.
Colony-forming unit (CFU) assay
After exposure to the FITC-mCNT solution with a concentration of 40 µg ml −1 for 1, 3 and 6 h, CD34 + cells were plated in triplicate in standard semisolid methylcellulose haematopoietic progenitor culture media (human MethoCult GF; Stem Cell Technologies, Vancouver, BC, Canada) at concentrations of 1 × 10 3 ml −1 . These culture plates were incubated at 37
• C in 5% CO 2 . Colonies were identified and enumerated 14 days later.
Confocal microscopy
CD34
+ cells were seeded at a density of 1 × 10 5 cells cm −2 on cover slips previously coated with poly-L-lysine (10 µg ml −1 ) for 45 min at 37
• C, 5% CO 2 . The cells exposed to 40 µg ml
FITC-mCNT and mCNT (the control) with the nanotubespearing method. Uptake was terminated by washing the cells twice with ice-cold PBS. After 1, 3 and 6 h incubation, the cells were fixed in 3.7% paraformaldehyde, stored overnight at 4 • C and examined under an inverted confocal laser scanning microscope (Carl Zeiss LSM510, Toronto, Canada) equipped with imaging software (LSM 5 Image Browser, Carl Zeiss).
Results
High cellular uptake of FITC-mCNT by CD34
+ cells
Highly efficient magnetic-field-driven gene delivery using mCNT into difficult-to-transfect primary neurons and B lymphocytes has been recently achieved [5] .
We also demonstrated that FITC-mCNT were effectively taken up by both MCF-7 and difficult-to-transfect THP-1 cells in the presence of a magnetic field [13] . In this paper, we examined the magnetic-field-driven uptake of FITC-mCNT into HSPC. FITC-mCNT with both fluorescent and magnetic properties were synthesized and freshly used for our uptake experiments as summarized in figure 1. Compared to the reported method using 1,3-dipolar cycloaddition as the key step to make watersoluble CNT with a yield of only 10% [25] , our synthesis of FITC-mCNT has much higher yield. In order to test our fluorescent and magnetic FITC-mCNTs for labelling HSPC, CD34
+ cells obtained from LP were exposed to solutions of different concentrations of FITC-mCNT or mCNT alone (10, 20 and 40 µg ml −1 ) in the presence of a magnetic field. The uptake efficiencies of these cells were determined using FACS 1, 3 and 6 h after the uptake. In LP CD34
+ cells, the FITC-mCNT uptake began efficiently (45% FITC uptake) 1 h after exposure even at the lowest FITC-mCNT concentration (10 µg ml −1 ) and reached its maximum efficiency (83% FITC uptake) after 6 h ( figure 2(A) ). FITC reached 83%, 90% and 100% in LP CD34 + cells at 6 h after uptake of FITC-mCNT with 10, 20 and 40 µg ml −1 concentrations, respectively. Although LP CD34
+ cells were ∼100% FITC-positive at 3 and 6 h after uptake of FITC-mCNT (40 µg ml −1 ), the mean fluorescence (MF) was the highest at 6 h after FITCmCNT uptake ( figure 2(B) ), which indicates more uptake of FITC-mCNT into CD34
+ cells as time increases. Therefore, we further investigated the internalization of the highest concentration of FITC-mCNT (40 µg ml −1 ) into these cells at 24 and 48 h after uptake. LP CD34 + cells were still about 98% FITC-positive 24 and 48 h after FITC-mCNT uptake, though their MF significantly dropped compared to that at 6 h (figure 2(C)), most likely due to FITC degradation over time.
To confirm that even more immature HSPC can efficiently uptake FITC-mCNT, we next studied the internalization of FITC-mCNT (40 µg ml −1 ) into CB-derived HSPC containing a larger immature stem cell fraction (CD34 + , CD38 − phenotype) than LP HSPC [31] . The efficient uptake started after about 1 h in CB CD34 + cells as demonstrated by ∼40% FITC uptake rate shown in figure 3(A) , which was lower compared to the result in LP CD34
+ cells. FITC-mCNT uptake reached 90% about 6 h after its exposure to the cells, similar to the result in LP CD34
+ cells, based on the FACS analysis ( figure 3(A) ). Confocal analysis also confirmed the efficient internalization of FITC-mCNT into CB CD34 + cells ( figure 3(B) ), similar to confocal data obtained in THP-1 and MCF-7 cells [13] . FITC-mCNT uptake was saturated at 6 h after its exposure to CB CD34 + cells similar to LP CD34 + cells ( figure 3(B) ). However, we did not observe a fluorescence signal by confocal analysis 1 h after FITC-mCNT exposure to cells, most probably due to a weak fluorescence signal (data not shown). The HSPC that were not exposed to FITC-mCNT (or the control) did not show any evidence of green fluorescence by confocal analysis, which is consistent with the FACS data in figure 3(B) . These data suggest that FITC-mCNT are efficiently internalized by HSPC in a timeand concentration-dependent manner, regardless of the HSPC source.
FITC-mCNT uptake does not affect CD34
+ cell viability
To investigate the cytotoxicity of mCNT, we studied the HSPC viability after FITC-mCNT uptake by trypan blue exclusion assay. With the exposure of FITC-mCNT to various concentrations (10, 20 and 40 µg ml −1 ), the viability of LP CB CD34 + cells was not compromised compared to the control even 6 h after delivery when the uptake rate reached its peak in these cells ( figure 4(A) ). As expected, the viability of CB CD34
+ cells was also not affected by the uptake of FITC-mCNT ( figure 4(B) ). There was no difference observed between the viability of LP and CB HSPCs using FITC-mCNT or mCNT alone in comparison with the control at 24 or 48 h after uptake (data not shown).
Differentiation of HSPC was not compromised by efficient FITC-mCNT uptake
It has been reported that CNT has no adverse effect on macrophages, was not cytotoxic and has no significant effect on adipogenic, osteogenic or chondrogenic differentiation of hMSC [16] . To investigate the long-term cytotoxicity effect of our magnetic-field-driven FITC-mCNT uptake and their impact on the differentiation of HSPC, we performed a colony unit assay (CFU) on FITC-mCNT-labelled HSPC 1, 3 and 6 h after uptake. After 14 days, colonies were identified and enumerated. No evidence was observed of cytotoxicity nor was the differentiation affected in FITCmCNT-labelled HSPC because there was no difference in overall colony number or type (CFU-GM: colony-forming unit of granulocyte/macrophage; BFU-E: burst forming unit of erythrocyte; CFU-GEMM: colony-forming unit of granulocyte macrophage-erythroid-megakaryocyte) between the FITCmCNT-labelled and the control HSPC ( figure 5 ). These observations suggest that FITC-mCNT internalization is not only efficient and safe, but it also does not alter the HSPC's properties.
Discussion
CNT have been proposed recently as new labels for cellular imaging and vehicles for delivering biomolecules into cells due to their nanoscale tip sizes (about 1.2 nm) that can lead to enhanced cell membrane penetration and low cytotoxicity [5, [14] [15] [16] . To date, only one study reported their effects on hMSC and suggested their use for tissue repair and regeneration. In this paper, we report for the first time that FITC-mCNT are efficiently taken up by both CB and LP HSPC. The delivery method is fast and safe and could be used for tracking the movement of the transplanted stem cells. The experimental results are in line with our expectations and previous findings by other researchers. This efficient mCNT delivery method does not depend on a targeted cell type because this method employs a physical magnetic force for delivery, unlike a biological mechanism like liposome or viral. In contrast to our findings, it has been shown that ferumoxides particles were taken up only by CB cells, but not PB cells [32] , indicating that our magnetic-field-driven FITC-mCNT can enter target cells regardless of cell type and source. Similar to the effect of COOH-functionalized single-walled CNT in hMSC [16] , our FITC-mCNT labelling or cell uptake has no unfavourable side-effects on viability or differentiation of HSPC. However, the magnetic-field-driven internalization of FITC-mCNT is much more rapid (began 1 h after the delivery) than internalization of CNTs into hMSC, which occurred at 24 h of incubation. Compared with other nanomaterial uptake using native or modified supermagnetic iron oxide (SPIO) [33, 34] , FITC-mCNT labelling or uptake is more efficient for stem cell labelling. Although the modification of these SPIO with an alternative strategy using HIV-Tat peptide led to highly efficient internalization of these particles into HSPC [24] , concerns have been raised with respect to the biosafety of a xenogenic protein and the requirement of a longterm incubation for internalization. In clinical trials involving HSPC, the safe labelling of stem cells should be performed within a period of less than 24 h after their isolation from patients. Our rapid FITC-mCNT labelling of HSPC might offer a solution for the difficulty of tracking the movement of transplanted HSPC in patients. Magnetic resonance imaging (MRI) provides a noninvasive in vivo method to studying the fate of transplanted cells labelled with magnetic nanoparticles. HIV-Tat peptide conjugation of cross-linked SPIO magnetic-particle-labelled human HSPC subsets have been reported to be tracked using the non-invasive MRI technology [24] . However, the detection of mCNT by standard MRI would not be possible due to its low resolution. It was recently reported that CNT functionalized with paramagnetic contrast agents (gadolinium chelates) could be detected in vivo with an MRI scanner [35] . Therefore, mCNT modified with a contrast agent such as gadolinium chelates could be used for in vivo detection and tracking of HSPC using MRI. Another possibility of detecting or tracking our mCNT-labelled HSPC in vivo might be through an optical cell tracking device due to the fact that CNT possess an optical transition in the near-infrared (NIR). The ability of NIR imaging to detect single-walled CNT in organisms and biological tissues has been recently demonstrated [15] .
In addition to their use for HSPC labelling and tracking, mCNT could also be used as a perfect platform to deliver genes into hard-to-transfect HSPC. The genetic modification of HSPC offers enormous potential for the treatment of genetic diseases of haematopoiesis owing to the ability to provide permanent correction [36] . However, transfection efficiency in HSPC is very low, which results from the low division frequency of the target cells and the quiescent nature of the most primitive HSPC [32, 37] . Though viral vectors are capable of efficiently transporting recombinant DNAs into a cell, the undesirable consequences of a viral integration process (i.e. haphazard activation or silencing of host genes), as well as the immunogenicity of viral particles, have recently raised safety concerns about viral vectors [38] . Hence an improved, safe and efficient non-viral gene delivery technique using mCNT might overcome these obstacles for stem-cellbased gene therapies.
Conclusion
In the current work, we demonstrated for the first time an efficient and safe mCNT-mediated labelling method for HSPC while not compromising viability or differentiation. Although still in the exploratory stage, mCNT-mediated labelling of HSPC described in this paper has exceptional long-term potential and would be an important technology with wide applications for in vivo labelling/tracking of HSPC and gene delivery into HSPC. The proposed technology can also be applied for gene therapy to cure cancer, hepatitis, AIDS, Alzheimer's disease and Parkinson's disease.
